Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities
Suellen J. Pommier; Ariel Hernandez; Esther Han; Kristen Massimino; Patrick Muller; Brian Diggs; Erin Chamberlain; Jennifer Murphy; Juliana Hansen; Arpana Naik; et al. (Profiled Authors: Juliana Hansen; Arpana Naik; Rodney Pommier; Su Ellen Johnson Pommier; John Vetto)
Annals of Surgical Oncology. 2012;19(2):527-535.Abstract
Background: The process by which breast cancer stem cells arise is unknown. It may be that the benign stem cells in breast tissue are transformed into malignant stem cells through the acquisition of genetic abnormalities. In this study, we collected and compared benign and malignant breast stem/progenitor cells to determine whether specific genetic abnormalities occur in breast cancer stem/progenitor cells within the human body. Methods: Fresh surgical specimens from benign and malignant breast tissues were obtained directly from the operating room and examined. Cells variably expressing stem cell-associated surface markers CD49f and CD24 were collected by fluorescence-activated cell sorting. The frequencies of these cells in benign and malignant breast tissues were ascertained. Oncogenetic mutation analyses were performed and expression of stem cell-associated genes was measured. Results: The frequencies of stem/progenitor cells were similar between benign and malignant tissues. Stem cell-associated gene expression also was similar between benign and malignant stem cells. Genetic mutations in the PIK/AKT pathway were found in 73% of the tumors' stem cells, specifically within two subpopulations. No mutations were found in stem/progenitor cell subpopulations from benign breast tissue. Conclusions: The results of this study suggest that, following malignant transformation, breast cancer stem/progenitor cells retain their stem cell functions and relative frequencies. In addition, they develop malignant capabilities by acquiring mutations in genes critical for maintaining normal cellular metabolism and proliferation. © 2011 The Author(s).
PMID: 21748247 PMCID: PMC3264874
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Suellen J. Pommier; Glenda G. Quan; Dara Christante; Patrick Muller; Amy E. H. Newell; Susan B. Olson; Brian Diggs; Leslie Muldoon; Edward Neuwelt; et al.Annals of Surgical Oncology. 2010;17(2):613-623.
Chuan-Hsiung Chang; Gary K. Scott; Wen-Lin Kuo; Xiaohui Xiong; Yevgeniya Suzdaltseva; John W. Park; Peter Sayre; Katrina Erny; Colin Collins; Joe W. Gray; et al.Oncogene. 1997;14(13):1617-1622.
Genevieve H. Nonet; Martha R. Stampfer; Koei Chin; Joe W. Gray; Colin C. Collins; Paul YaswenCancer Research. 2001;61(4):1250-1254.
Appears in this Document